ENDOCRINE ACTIVITY INDEX
Live / Registered — Registered (as of 20 Aug 2024)
What this means for you
Registered since 20 Aug 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98322723
- Registration number
- 7483681
- Mark type
- Stylized text
- Filed
- 19 Dec 2023
- Registered
- 20 Aug 2024
- Attorney of record
- Naira Simmons
Goods and services
- Class 005 — Pharmaceuticals: Clinical diagnostic testing kits comprised of medical diagnostic reagents and assays for testing biopsy and other tissue samples for use in disease detection, namely, breast cancer; clinical diagnostic testing kits comprised of medical diagnostic reagents and assays for breast cancer surveillance, namely, for measuring amounts of genomic and other biomarkers contacted with the reagent, such as estrogen receptor (ER), progesterone receptor (PR) associated biomarkers, and other suitable biomarkers for monitoring breast cancer occurrence, recurrence, response to various chemotherapies, hormone therapies, radiation therapies, or other suitable treatments.
Owner
- Delphi Diagnostics, Inc., Houston, TX, US
- Delphi Diagnostics, Inc., Houston, TX, US
Prosecution history
- 20 Aug 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Aug 2024 — REGISTERED-SUPPLEMENTAL REGISTER
- 11 Jul 2024 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 11 Jul 2024 — USE AMENDMENT ACCEPTED
- 10 Jul 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 10 Jul 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 10 Jul 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 30 Jun 2024 — AMENDMENT TO USE PROCESSING COMPLETE
- 30 Jun 2024 — USE AMENDMENT FILED
- 30 Jun 2024 — TEAS AMENDMENT OF USE RECEIVED
- 30 Jun 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Apr 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 11 Apr 2024 — NON-FINAL ACTION E-MAILED
- 11 Apr 2024 — NON-FINAL ACTION WRITTEN
- 08 Apr 2024 — ASSIGNED TO EXAMINER